Back to All Events

Cognitive Impairment in Substance Use Disorder Treatment: Neurologic Informed Care

The American Society of Addiction Medicine (ASAM) is the leading professional medical society representing physicians, clinicians and associated professionals in addiction medicine. ASAM is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction. The ASAM Criteria for the substance use disorder treatment is the most widely used and comprehensive set of standards for placement, continued service, and transfer of patients with addiction and co-occurring conditions. Most states use the ASAM Criteria as the foundation of their requirements for addiction treatment. The 4th Edition of the ASAM Criteria for adults was released in December 2023 and for the first time includes a chapter addressing treatment for individuals with cognitive impairment. 

John D. Corrigan, PhD, ABPP, was a member of the writing group for this chapter. In this webinar he will introduce the new ASAM expectations for the treatment of persons with cognitive impairment, including "Neurologic Informed Care” as described in the new criteria. Implications for the identification of people in treatment who have a history of brain injury, as well as the use of accommodations to make treatment more accessible, will be discussed.

ASL interpretation, Spanish interpretation, and live English captions will be provided during the webinar. If you require additional accommodations to participate, or if you have any questions about the webinar, please contact the TBI TARC at tbitarc@hsri.org

Previous
Previous
June 5

Vulnerable Populations Series, Part 2: Human Trafficking and Brain Injury Implications

Next
Next
June 18

Vulnerable Populations Series, Part 3: Beyond the Fight: UFC, MMA, and Brain Injury